Biotek YK11

Inhibit Myostatin to take building muscle to a whole new level.

Biotek YK11 is an amazing compound that doubles as a myostatin inhibitor and as a very potent SARM.

Myostatin is a protein the body releases that limits the growth of the muscle cells of the body, thus stopping us from what some would say as reaching our full potential.

Being able to inhibit Myostatin to even a small degree will allow the user to drastically push past the genetic boundaries of how much muscle your body can build and break through plateaus with ease.

That may sound amazing but the real draw card for YK-11 is the fact it possesses a dual mechanism meaning that YK-11 acts as both a SARM and a Myostatin inhibitor, whereas many other compounds only work as one or the other. YK-11 allows the user to build muscle and reach the desired goals in a rapid and highly desirable fashion.

Independent research has shown YK-11 to be a significantly more powerful anabolic and androgenic compound than the anabolic steroid Dihydrotestosterone (DHT), with an even bigger bonus of not experiencing the undesirable side effects of DHT which can include prostate enlargement and hair loss.

Key points:

• Rapid gains in lean muscle and strength
• Improvement of overall athletic performance
• Boost strength
• reduce body-fat
• Prevent muscle wastage from reduced calories while cutting
• Enhancement of quality of life
• Hormonal levels return to baseline after usage stops
• Inhibit Myostatin

Dosage Recommendation: Independent lab research has shown a recommended dosage of 10mg twice per day split up between morning and afternoon doses to provide the greatest result, YK-11 has a half life of 6-10 hours. Independent research has shown cycles can range between 8-10 weeks.

10mg per capsule // 60 capsules per bottle
Made in USA

These products are not for use in preventing, curing, or treating a particular disease or ailments. For research only, not for human consumption.

It is important to note that this item is not an approved medication or treatment by regulatory authorities such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Its use is primarily associated with experimental and research purposes. Additionally, the safety and long-term effects of this product are not fully understood, and it may have potential risks and side effects.